Literature DB >> 6230183

Immunoglobulin production by peripheral blood mononuclear cells in patients with alcoholic liver disease.

M A Rodriguez, J D Montano, R C Williams.   

Abstract

Baseline unstimulated IgG and IgM production by peripheral blood mononuclear cells from 16 patients with alcoholic liver disease (ALD) was slightly higher than that of normal controls. No significant differences were noted when IgG and IgM production were studied using 7 day cultures of B cells from 25 ALD and 22 normal controls; pokeweed mitogen stimulated IgG and IgM production also showed no difference between 26 ALD and 22 normal controls. B cells from patients with ALD showed marked hyporesponsiveness particularly in IgG production in response to T cell derived helper factors. Pre-incubation of B cells with three different concentrations of alpha-interferon followed by addition of helper factor and 7 day culture showed markedly diminished IgG production in ALD patients as compared with controls. When normal peripheral blood mononuclear cells were pre-incubated with ALD plasmas for 2 h, significant increments in both IgG and IgM production were recorded in comparison to pre-incubations with normal plasmas. The ambient state of B cell activation is considerably different in ALD from normal subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230183      PMCID: PMC1535830     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Inhibition of the primary in vitro antibody response by interferon preparations.

Authors:  H M Johnson; B G Smith; S Baron
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Production of tetanus antitoxin by patients with hepatic cirrhosis.

Authors:  W P HAVENS; R M MYERSON; J KLATCHKO
Journal:  N Engl J Med       Date:  1957-10-03       Impact factor: 91.245

3.  Suppressive effect of interferon on the humoral immune response to sheep red blood cells in mice.

Authors:  B R Brodeur; T C Merigan
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

4.  Effects of interferon on antibody synthesis in vitro.

Authors:  R H Gisler; P Lindahl; I Gresser
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

5.  Hyperglobulinaemia in liver disease.

Authors:  D R Triger; R Wright
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

6.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

7.  Anti-Salmonella agglutinins in chronic active liver disease.

Authors:  R L Protell; R D Soloway; W J Martin; L J Schoenfield; W H Summerskill
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

8.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

9.  Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.

Authors:  A D Bankhurst; R C Williams
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  Antibodies to human albumin in cirrhotic sera.

Authors:  S Hauptman; T B Tomasi
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  2 in total

1.  Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes.

Authors:  L S Milner; M T Houser; P C Kolbeck; D L Antonson; T L McDonald; R S Markin; B W Shaw
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

2.  Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

Authors:  U McKeever; C O'Mahony; C A Whelan; D G Weir; C Feighery
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.